Full archive
Bioinformatics & AI
Week of 30 June 2026
6 articles
Geno'X Veille — genox-veille.fr
Key takeaways this week
- ►AI-CURA — LLM workflow (DeepSeek-R1) automating ACMG variant classification with ClinGen expert concordance.
- ►Long-read vs short-read in 310 neurological patients: comparable yield, equivalent cost, the genome moves first-tier.
- ►Long-read karyotyping in AML: an actionable prognostic result within 72 hours, reproducible across laboratories.
- ►Near-perfect genome sequencing — the Nat Genet perspective framing the complete genome, not panels, as the single test.
Category:
Filters··Min. score
6 articles of 6
Sort
AI-CURA
PubMed★ Top pick
⭐ À la une
AI-CURA, an automated LLM workflow for high-accuracy genetic variant classification
Automated genetic variant classification by LLM following ACMG/AMP/ClinGen
0
Clinical pipelineLLM appliedNew tool
Sci Transl Med 2026· JunRead
Long-read
PubMed★ Top pick
Systematic evaluation of long-read and short-read sequencing in neurological disorders diagnosis: a direct comparison study of 310 patients
Genetic neurological disorders — direct comparison of long-read vs short-read WGS
0
Long-readLong-read sequencingBenchmark
NPJ Genom Med 2026· JunRead
Long-read
PubMed★ Top pick
Rapid and Reproducible Karyotyping with Long Read Sequencing in AML Patients
Acute myeloid leukemia — rapid karyotyping by long-read sequencing
0
Long-readLong-read sequencingClinical pipeline
Blood Adv 2026· JunRead
Clinical pipeline
PubMed★ Top pick
Validation of an integrated metagenomic pipeline combining optimized wet-lab processing and tiered reporting for CSF pathogen detection
Central nervous system infections — CSF pathogen detection by metagenomics
0
Clinical pipelineClinical pipelineBenchmark
Microbiol Spectr 2026· JunRead
Long-read
PubMedNear-perfect genome sequencing in medical genetics
Medical genetics — toward near-perfect genome sequencing (one-test paradigm)
0
Long-readLong-read sequencingClinical pipeline
Nat Genet 2026· JunRead
Algorithm benchmark
PubMedComprehensive comparison of homologous recombination deficiency predictors in early-stage triple-negative breast cancer
Triple-negative breast cancer — comparison of homologous recombination deficiency (HRD) predictors
0
Algorithm benchmarkBenchmarkPathogenicity prediction
Breast Cancer Res 2026· JunRead
References and sources
- Automated genetic variant classification by LLM following ACMG/AMP/ClinGen. Sci Transl Med 2026. PMID 42341082. Score 10/10. https://pubmed.ncbi.nlm.nih.gov/42341082/
- Genetic neurological disorders — direct comparison of long-read vs short-read WGS. NPJ Genom Med 2026. PMID 42373670. Score 10/10. https://pubmed.ncbi.nlm.nih.gov/42373670/
- Central nervous system infections — CSF pathogen detection by metagenomics. Microbiol Spectr 2026. PMID 42370707. Score 9/10. https://pubmed.ncbi.nlm.nih.gov/42370707/
- Acute myeloid leukemia — rapid karyotyping by long-read sequencing. Blood Adv 2026. PMID 42349015. Score 10/10. https://pubmed.ncbi.nlm.nih.gov/42349015/
- Medical genetics — toward near-perfect genome sequencing (one-test paradigm). Nat Genet 2026. PMID 42362790. Score 7/10. https://pubmed.ncbi.nlm.nih.gov/42362790/
- Triple-negative breast cancer — comparison of homologous recombination deficiency (HRD) predictors. Breast Cancer Res 2026. PMID 42351273. Score 7/10. https://pubmed.ncbi.nlm.nih.gov/42351273/